Surveillance for Onchocerciasis-Associated Epilepsy and OV16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening

Surveillance for Onchocerciasis-Associated Epilepsy and OV16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening

To eliminate onchocerciasis-associated morbidity, it is important to identify areas where there is still high ongoing <i>Onchocerca volvulus</i> transmission. Between 2015 and 2021, door-to-door surveys were conducted in onchocerciasis-endemic villages in Cameroon, the Democratic Republi...

詳細記述

書誌詳細
主要な著者: Alfred Dusabimana, Joseph Nelson Siewe Fodjo, Michel Mandro Ndahura, Bruno P. Mmbando, Stephen Raimon Jada, Annelies Boven, Eric De Smet, Tony Ukety, Alfred K. Njamnshi, Anne Laudisoit, Steven Abrams, Robert Colebunders
フォーマット: 論文
言語:English
出版事項: MDPI AG 2022-02-01
シリーズ:Pathogens
主題:
onchocerciasis
onchocerciasis-associated epilepsy
epilepsy prevalence
incidence
ivermectin
OV16 antibodies
オンライン･アクセス:https://www.mdpi.com/2076-0817/11/3/281

インターネット

https://www.mdpi.com/2076-0817/11/3/281

類似資料